Las Vegas, NV -- (SBWIRE) -- 10/01/2013 -- Beststocksondemand.com, is a financial newsletter and blog focused on shedding light on under-discovered small cap companies. Our team of professionals from various backgrounds work diligently to bring our members the best penny stock picks, stock market commentary, and news on all types of OTCBB and Pink Sheet companies, Inovio Pharmaceuticals Inc (NYSEMKT:INO), Myriad Genetics, Inc. (NASDAQ:MYGN), Geron Corporation (NASDAQ:GERN), McEwen Mining Inc (NYSE:MUX)
Inovio Pharmaceuticals Inc (NYSEMKT:INO) gained volume of 5.36 million shares and the average volume of the stock remained 9.97 million shares. The 52 week range of the stock remained $0.44 - $3.03 and the day range was $2.02 - $2.14.The stock opened the session at $2.05, and closed the session at $2.07. The stock showed a negative performance of -4.17% in previous trading session. Inovio Pharmaceuticals, Inc. is engaged in the development of a new generation of vaccines, called synthetic vaccines, focused on cancers and infectious diseases. The Company's SynCon technology enables the design of universal vaccines capable of providing cross-protection against existing or changing strains of pathogens, such as influenza and human immunodeficiency virus (HIV).
Will INO Bounce Back After yesterday’s Sharp Sell off? Find Out Here
In previous session, Myriad Genetics, Inc. (NASDAQ:MYGN) traded 3.80 million shares and the average volume of the stock remained 2.06 million shares. The 52 week range of the stock remained $22.61 - $38.27. The stock was a bear and dropped -9.34%, while its closing price stayed at $23.50. The market capitalization of the stock remained 1.89 billion. The half-yearly trend of the stock remained negative -7.52%. Myriad Genetics, Inc. (Myriad) is a molecular diagnostic company. The Company is focused on developing and marketing predictive medicine, personalized medicine and prognostic medicine tests. It performs all of its molecular diagnostic testing and analysis in its own reference laboratories. These technologies include the cornerstone technologies of biomarker discovery, high-throughput deoxyribo nucleuc acid (DNA) sequencing, ribo nucleic acid (RNA) expression and multiplex protein analysis.
Is it the Right to Grab MYGN after the Recent Slump? Get Free Trend Analysis Here
Geron Corporation (NASDAQ:GERN) volume of the stock was 3.79 million shares in the most recent session and the average volume remained 1.62 million shares. The stock plunged -9.46% and finished the prior session at the closing price of $3.35. Geron Corporation (Geron) is a clinical-stage biopharmaceutical company developing a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. Telomerase is an enzyme that enables cancer cells to maintain telomere length, which provides them with the capacity for limitless cellular replication.
Will GERN Reach the Bottom after Yesterday’s Correction? Find Out Here
McEwen Mining Inc (NYSE:MUX) traded with volume of 3.39 million shares and the average volume of the stock remained 4.49 million shares. The stock decreased -5.14% and finished the trading at $2.40. The market capitalization of the stock remained 716.63 million. The beta of the stock remained 0.24. McEwen Mining Inc. (McEwen Mining), formerly US Gold Corporation, is engaged in the exploration for and production of precious metals in the United States, Mexico and Argentina. McEwen Mining’s operating segments include USA and Mexico.
Has MUX Found The Bottom and Ready To Move Up? Find Out Here
About Best Stock on Demand
Beststocksondemand.com is an exciting online financial terminal where stock readers, traders and investors as well as market analysts can come to discover new opportunities, ideas, situations and news. Beststocksondemand.com goal is finding the most Undervalued or should we say Value Stocks or the Next Emerging Growth Stock that might be unnoticed by Wallstreet. Beststocksondemand.com is constantly searching for exceptional investment situations that can profit both investors and traders in order to grow their gains on a well balanced portfolio.
Beststocksondemand.com is also a well-respected marketing and research firm that mainly focuses on Best Stocks on Demand, Micro-Cap Stocks and Small Cap Stocks. Beststocksondemand.com uses its strategic corporate communication services to increase investor awareness of your company. We can support developing, emerging growth and deep-rooted companies in their marketing therefore creating a more dominant and operative investor alertness.
The assembled information disseminated by Beststocksondemand.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Beststocksondemand.com does expect that investors will buy and sell securities based on information assembled and presented in beststocksdaily.com. PLEASE always do your own due diligence, and consult your financial advisor.
Please read Our Full Disclaimer at: http://www.beststocksondemand.com/disclaimer.html
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)